Not yet recruiting
Surufatinib in Combination With Iparomlimab and Tuvonralimab Injection and AG Chemotherapy for Neoadjuvant Therapy of HRPC or BRPC
NCT07833241
- Conditions
- Borderline Resectable Pancreatic Cancer, Digestive System Diseases, Digestive System Neoplasms, +7 more
- Locations
-
- Shanghai Zhongshan Hospital Shanghai, China